anmelden
OMX Nordic 40
2.733,09
PKT
+2,26
PKT
+0,08
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.11.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 24.11.25 | Hennes Mauritz (H M, H&M) Equal Weight | Barclays Capital | |
| 21.11.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 20.11.25 | Nokia Buy | Deutsche Bank AG | |
| 20.11.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 20.11.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 20.11.25 | Nokia Buy | Jefferies & Company Inc. | |
| 19.11.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 19.11.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 19.11.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 19.11.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 18.11.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 18.11.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 18.11.25 | Novo Nordisk Neutral | UBS AG | |
| 18.11.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 17.11.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 14.11.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.11.25 | AstraZeneca Outperform | Bernstein Research | |
| 12.11.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 11.11.25 | Novo Nordisk Neutral | UBS AG | |
| 11.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.11.25 | Novo Nordisk Halten | DZ BANK | |
| 10.11.25 | AstraZeneca Halten | DZ BANK | |
| 10.11.25 | Novo Nordisk Neutral | UBS AG | |
| 10.11.25 | AstraZeneca Outperform | Bernstein Research | |
| 10.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.11.25 | Nokia Buy | Deutsche Bank AG | |
| 10.11.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 10.11.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.11.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.11.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 07.11.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 07.11.25 | AstraZeneca Buy | UBS AG | |
| 07.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.11.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 06.11.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.25 | AstraZeneca Buy | UBS AG | |
| 06.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.11.25 | Novo Nordisk Neutral | UBS AG |
